Recruiting NA Neurologic Disorders

New treatment option for Neurologic Disorders

Official title Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders

ClinicalTrials.gov ID: NCT07295652

What this study is testing

What it's testing
Neuropsychiatric disorders are extremely common, severe, and disabling conditions. In the field of psychiatry, they notably include schizophrenia, mood disorders (depressive and bipolar disorders), autism spectrum or neurodevelopmental disorders, obsessive-compulsive disorder, eating disorders, and personality disorders.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • For patients:
  • Aged over 18 years
  • Diagnosed with a psychiatric disorder according to ICD-10 by a psychiatrist (F10-F98) or diagnosed with a neurological disorder according to ICD-10...
  • Provided written informed consent
  • Affiliated with a social security scheme For healthy volunteers:

You likely can't join if

  • For healthy volunteers:
  • Current diagnosis of a psychiatric disorder according to ICD-10 (F20-F98) or current prescription of a psychotropic medication, or diagnosis of a...
  • History of depression (F32)
  • Substance use disorder (excluding tobacco)
  • Neurological history (e.g., stroke, coma, epilepsy, neuroinflammatory or neurodegenerative disease) or identified cognitive disorder
  • Inability to complete cognitive testing (e.g., due to motor or sensory impairment) For participants undergoing MRI (without contrast agent):
See the full eligibility criteria
Who can join
  • For patients:
  • Aged over 18 years
  • Diagnosed with a psychiatric disorder according to ICD-10 by a psychiatrist (F10-F98) or diagnosed with a neurological disorder according to ICD-10 by a neurologist (G00-G99)
  • Provided written informed consent
  • Affiliated with a social security scheme For healthy volunteers:
  • Aged over 18 years
  • Provided written informed consent
  • Affiliated with a social security scheme
What rules you out
  • For healthy volunteers:
  • Current diagnosis of a psychiatric disorder according to ICD-10 (F20-F98) or current prescription of a psychotropic medication, or diagnosis of a neurological disorder according to ICD-10 (G00-G99)
  • History of depression (F32)
  • Substance use disorder (excluding tobacco)
  • Neurological history (e.g., stroke, coma, epilepsy, neuroinflammatory or neurodegenerative disease) or identified cognitive disorder
  • Inability to complete cognitive testing (e.g., due to motor or sensory impairment) For participants undergoing MRI (without contrast agent):
  • Presence of MRI contraindications: non-MRI-compatible pacemaker, heart valve, implant, or metallic foreign body
  • Pregnancy at the time of MRI

The study team makes the final eligibility decision.

Where it's taking place

  • Paris, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.